Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesVernoniaAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraStem Cell TransplantationGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsCell- and Tissue-Based TherapyHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesNeoplasmsKidney TransplantationHematopoiesisMice, Inbred C57BLCombined Modality TherapyRecurrenceRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTreatment OutcomeBone Marrow ExaminationLeukemia, Myeloid, AcuteCell Line, TumorImmunosuppressive AgentsTime FactorsGraft RejectionRemission InductionHematologic NeoplasmsHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionImmunosuppressionLymphocyte DepletionLeukemia, MyeloidAcute DiseaseLeukocyte TransfusionCell DifferentiationLymphoma, Non-HodgkinHeart TransplantationT-LymphocytesCell TransplantationColony-Forming Units AssaySevere Combined ImmunodeficiencyChimeraCell ProliferationHLA AntigensSurvival AnalysisMyelodysplastic SyndromesApoptosisRetrospective StudiesMesenchymal Stem Cell TransplantationLung TransplantationLymphocyte TransfusionCyclosporineActuarial AnalysisBone DensityHematologic DiseasesAntineoplastic AgentsNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsStem CellsCarmustineCells, CulturedOrgan TransplantationPancytopeniaFollow-Up StudiesFlow CytometryGraft vs Tumor EffectSurvival RateGraft vs Leukemia EffectCytarabineGranulocyte Colony-Stimulating FactorLeukocyte CountCytomegalovirus InfectionsMice, Inbred BALB CSpleenBone ResorptionMelphalanDisease-Free SurvivalEtoposideAntigens, CD34